TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 92 filers reported holding TANGO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $16,262 | -45.5% | 4,116,949 | 0.0% | 1.07% | -46.4% |
Q4 2022 | $29,848 | -99.8% | 4,116,949 | 0.0% | 2.00% | +91.7% |
Q3 2022 | $14,903,000 | -27.0% | 4,116,949 | -8.7% | 1.04% | -32.5% |
Q2 2022 | $20,421,000 | -45.0% | 4,507,843 | -8.0% | 1.54% | -45.8% |
Q1 2022 | $37,136,000 | -30.1% | 4,899,185 | 0.0% | 2.85% | -9.8% |
Q4 2021 | $53,149,000 | +8.9% | 4,899,185 | +25.6% | 3.16% | +59.4% |
Q3 2021 | $48,814,000 | – | 3,899,185 | – | 1.98% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 19,363,975 | $70,098,000 | 40.96% |
Boxer Capital, LLC | 6,871,642 | $24,875,000 | 1.40% |
TCG Crossover Management, LLC | 1,172,250 | $4,244,000 | 1.27% |
Cormorant Asset Management, LP | 4,116,949 | $14,903,000 | 1.04% |
Bain Capital Life Sciences Investors, LLC | 1,921,790 | $6,957,000 | 0.83% |
Samsara BioCapital, LLC | 630,000 | $2,281,000 | 0.53% |
EcoR1 Capital, LLC | 4,201,414 | $15,209,000 | 0.45% |
Southpoint Capital Advisors LP | 4,500,000 | $16,290,000 | 0.44% |
HARVARD MANAGEMENT CO INC | 708,385 | $2,564,000 | 0.32% |
Avoro Capital Advisors LLC | 1,550,000 | $5,611,000 | 0.10% |